You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 22, November 24, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (172)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Primary Cytomegalovirus and Opportunistic Infections

Incidence in Renal Transplant Recipients

Satya N. Chatterjee, MD, FRCS; Milan Fiala, MD; John Weiner, PhD; John A. Stewart, MD; Barbara Stacey; Nancy Warner, MD

JAMA. 1978;240(22):2446-2449.


Abstract

Thirty-five renal allograft recipients were studied concerning the relationship between cytomegalovirus (CMV), herpes simplex virus (HSV), and opportunistic bacterial and fungal infections. The incidence of opportunistic infections was determined for patients whose tests prior to transplantation were seronegative in complement fixation and indirect hemagglutination assays of CMV antibody and for those patients whose tests were seropositive. Among the six seronegative patients with seronegative tests, four (66%) experienced active CMV infection within two months, and four died of Candida or Aspergillus infection within six months after transplantation. Among the 22 patients with seropositive tests, only one (4%) had a fungal infection and it was nonfatal (P<.05). The increased morbidity and mortality due to fungal and bacterial infections in transplant recipients with seronegative CMV tests appears, therefore, to be related to primary CMV infection rather than to generalized immunodeficiency.

(JAMA 240:2446-2449, 1978)



Author Affiliations

From the Department of Medicine, University of California, Irvine (Dr Fiala and Ms Stacey), Departments of Medicine (Dr Weiner), Surgery (Dr Chatterjee), and Pathology (Dr Warner), University of Southern California School of Medicine, Los Angeles, and Center for Disease Control, Atlanta (Dr Stewart).


Footnotes

Reprint requests to University of California, Davis, Sacramento Medical Center, 4301 X St, Suite 249, Sacramento, CA 95817 (Dr Chatterjee).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Longitudinal Analysis of Levels of Immunoglobulins against BK Virus Capsid Proteins in Kidney Transplant Recipients
Randhawa et al.
CVI 2008;15:1564-1571.
ABSTRACT | FULL TEXT  

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance et al.
NEJM 1999;340:1462-1470.
ABSTRACT | FULL TEXT  

Preemptive Ganciclovir Therapy in Cytomegalovirus-Seropositive Renal Transplants Recipients
Conti et al.
Arch Surg 1995;130:1217-1222.
ABSTRACT  

Prophylaxis of Primary Cytomegalovirus Disease in Renal Transplant Recipients: A Trial of Ganciclovir vs Immunoglobulin
Conti et al.
Arch Surg 1994;129:443-447.
ABSTRACT  

Clinical Patterns of Cytomegalovirus Disease After Liver Transplantation
Stratta et al.
Arch Surg 1989;124:1443-1450.
ABSTRACT  

The Indirect Effects of Cytomegalovirus Infection on the Outcome of Organ Transplantation
Rubin
JAMA 1989;261:3607-3609.
ABSTRACT  

Prophylaxis of Serious Cytomegalovirus Infection in Renal Transplant Candidates Using Live Human Cytomegalovirus Vaccine: Interim Results of a Randomized Controlled Trial
Brayman et al.
Arch Surg 1988;123:1502-1508.
ABSTRACT  

Infectious Complications in Heart Transplant Recipients Receiving Cyclosporine and Corticosteroids
HOFFLIN et al.
ANN INTERN MED 1987;106:209-216.
ABSTRACT  

Human Cytomegalovirus Infection and Disorders of the Nervous System
Bale
Arch Neurol 1984;41:310-320.
ABSTRACT  

Prevention of Cytomegalovirus Infection by Cytomegalovirus Immune Globulin After Marrow Transplantation
MEYERS et al.
ANN INTERN MED 1983;98:442-446.
ABSTRACT  

Fibrosing Uremic Pleuritis Complicated by Thoracic Empyema
McCabe et al.
Arch Intern Med 1982;142:1369-1370.
ABSTRACT  

Human Polyomavirus Infections with JC Virus and BK Virus in Renal Transplant Patients
HOGAN et al.
ANN INTERN MED 1980;92:373-378.
ABSTRACT  

Pneumococcal Infections After Human Bone-Marrow Transplantation
WINSTON et al.
ANN INTERN MED 1979;91:835-841.
ABSTRACT  

Cytomegalovirus: The Troll of Transplantation
Balfour
Arch Intern Med 1979;139:279-280.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.